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ABSTRACT

Methods for screening mutations that affect the synthesis of
plant small molecules or compounds capable of activating a

mammalian nuclear receptor protein and systems for rapidly
assigning functionality to genes that regulate plant secondary
metabolism are provided.
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METHODS FOR SCREENING FOR GENES
AND SMALL MOLECULES THAT ACTIVATE
MAMMALIAN RECEPTOR PROTEINS

nuclear receptor ligand binding domain Which is operably
linked to a transcription factor DNA binding domain and a

transactivating transcriptional activator domain; and a gene
encoding a visible marker operably linked to a transcription
activator sequence and a promoter, Wherein the transgenic
plant or plant tissue overexpresses the visible marker.
In another aspect of the invention there is provided a plant
cell line derived from the transgenic plant or plant tissue of the
invention.

FIELD OF THE INVENTION

The invention relates to methods for screening mutations
that affect the synthesis of plant small molecules or com

pounds capable of activating a mammalian nuclear receptor
protein. More particularly, the invention relates to the use of

BRIEF DESCRIPTION OF THE DRAWINGS

transgenic plants encoding a mammalian receptor Whose acti
vation is linked to a gene encoding a visible reporter gene to

FIG. 1 is a schematic draWing illustrating the elements of

identify genes encoding small molecules or compounds that
activate the receptor.

the nuclear receptor protein (NRP) inducible system. T-DNA
is delineated by the right and left borders, labeled RB and LB

BACKGROUND OF THE INVENTION

in boxes at either end of the element. Block arroWs Within the

element represent promoter sequences 35S from Cauli?ower

mosaic virus; NOS, nopaline synthase promoter; 6X UAS, six

Plants produce many small molecules With speci?c and

potent biological activity. These are commonly economically
important, either because they are valuable commercial prod
ucts, or because they have regulatory functions as plant hor

20

tandem repeats of the yeast GAL4 upstream activator
sequence folloWed by —46 to +1 region of the 35S promoter

(encompassing the TATA box sequence). E91, polyadenyla

mones or intracellular messengers. The genetic regulation of

tion addition sequence of the pea ribulose bisphosphate car

the synthesis of such compounds is often unknown. For
example only a small fraction of the Arabidopsis genome is
recogniZed as being involved in plant secondary metabolism.
The problems in elucidating these pathWays include loW
accumulation levels, transient or tissue-speci?c expression,
or the complications associated With long multi-step path

boxylase small subunit gene E9; NOS], nopaline synthase
poly(A) terminator sequence; 3A1, poly(A) addition
25

Ways. To overcome these problems a strategy has been

devised combining activation tagging mutagenesis (ATM)
With pharmacological high throughput screening (HTS). In
this, ATM of Nicoliana Zabacum protoplasts are used to pro
duce a mutant population of microcallus cultures, and indi
vidual clones that over-accumulate products With a speci?c
biological activity are then selected after HTS. These mutant
clones are then used to isolate the tagged genes responsible
for this accumulation. This enables product-relevant genes to
be identi?ed Without the requirement for understanding the
metabolic pathWay. HoWever, because of the random nature
of ATM, and the large genome siZe, as many as 300,000

30

at the C-terminus.

FIG. 2A-D are photographs of the upper parts of leaves of

an Arabidopsis transgenic line after treating the seedlings
With the indicated concentration of various inducers. Seed

lings Were exposed for 48 hours before vieWing under blue
35

(470 nm) Wavelength light at 40x magni?cation. A. Control.
Leaf surface With no inducer; or treated With 1 microMol

dexamethasone (B); 30 microMol progesterone (C); or 30

microMole hydrocortisone.
FIGS. 3A-3D provide an example of GFP ?uorescence
40

from induced single protoplasts derived from glucocorticoid

45

NRP transgenic tobacco. TWo-day-old cells Were induced for
20 hours With 10 microMol dexamethasone before photo gra
phy. A. Protoplasts at 40x magni?cation. B. and C. l00><
magni?cation. D. Photograph of elongating cells in same dish
taken three days later at l00><. All green color is due to GFP

individual mutants Would need to be screened to cover the

entire genome. Thus, there is a need for systems and methods

to signi?cantly increase screening throughput.
SUMMARY OF THE INVENTION

sequence of the pea rbc S3A gene. GVG, gene encoding the

trimeric glucocorticoid-inducible transcription factor. The
yeast GAL4 protein is at the N-terminus, the transactivating
domain from herpes simplex virus VP16 protein, and the
hormone binding domain of the rat glucocorticoid receptor is

?uorescence. Chloroplasts are evident as small red dots as

In one aspect of the invention there is provided a method

chlorophyll auto?uoresces under blue Wavelength light. Yel

for screening mutations that affect the synthesis of plant small

loWish spots in some cells are nuclei that are actually ?uo

molecules or compounds capable of activating a mammalian

rescing intensely green but appear yelloW from the length

nuclear receptor proteins comprising

50

ened exposure times used to enable the green ?uorescence in

(1) transforming a plant With a vector comprising a consti
tutive promoter operably linked to the mammalian nuclear

the cytoplasm to be captured on ?lm. Although not shoWn,
non-induced Wild type cells display only red auto?uores

receptor ligand binding domain Which is operably linked to a
transcription factor DNA binding domain and a transactivat
ing transcriptional activator domain; and a gene encoding a
visible marker operably linked to a transcription activator

cence and no green coloration.
55

sequence and a promoter, to obtain a transgenic plant;

This invention provides methods and systems for signi?

(2) isolating protoplasts from the transgenic plant;

cantly increasing screening throughput of mutants by using

(3) mutageniZing the protoplasts to form mutageniZed pro

toplasts;

the plant cell itself to screen for biological activity. To this
60

(4) culturing the mutageniZed protoplasts into microcalli;
and

genic plant or plant tissue comprising a vector comprising a
constitutive promoter operably linked to the mammalian

end, transgenic lines of N. Zabacum and Arabidopsis have
been engineered to express nuclear receptor proteins (NRPs)
that are linked to the expression of a visible marker protein,
e.g., green ?uorescent protein (GFP) or luciferase. Cells from
this line exposed to activators of the NRP are identi?able by

(5) selecting microcalli that overexpress the visible marker
gene.
In another aspect of the invention there is provided a trans

DETAILED DESCRIPTION OF THE INVENTION

65

visible screening, for example, under a ?uorescence micro
scope for the accumulation of GFP. These transgenic lines are
used to produce a population of mutant protoplasts by ATM,
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and individual cells that over-accumulate relevant products
are identi?ed by marker protein, e. g., GFP expression. Each
“positive” cell line may be used to identify the type of com

times. All of the enZymes required for the synthesis of these

MenZha-speci?c terpenoids are expressed exclusively in glan

pound responsible for the biological activity, and for recovery
of genomic DNA adjacent to the activation T-DNA tag (plas

dular cells With the primary mechanism of regulation occur
ring at the transcriptional level (Lange et al. 2000, Proc. Natl.
Acad. Sci USA, 97:2934-9; McCaskill and Croteau 1995,

mid rescue, genomic Walking). Candidate sequences are

Planta, 197149-56).

evaluated for their ability to reproduce the marker-positive
phenotype, e.g., GFP-positive When inserted into protoplasts,

The present methods and systems alloW for screening of
extremely high numbers of cells harboring distinct activation

and may be sequenced by high throughput DNA sequencing.
Overexpression of the positive genetic material is evaluated

mutations. Considering the genome siZe of plants, such as
Nicoliana Zabacum and Arabidopsis, Which are particularly

in Whole plants to establish its metabolic impact at this level.

In particular, the focus is on products With biological activity

Well suited for such studies, such high throughput screening
capacity is essential. The experimental strategy transforms

at mammalian nuclear receptor proteins, such as corticoster

the desired phenotype, that of elevated accumulation of plant

oid NRP, Liver X receptor, estrogen NRP, glucocorticoid,
mineralcorticoid, androgen, progesterone group, famesoid X
receptor, vitamin D receptor, and peroxisome proliferator

derived molecules, to a visible response su?iciently sensitive
to permit detection at an individual cell stage. A functional

approach is thus applied in tWo respects, that of the biological
activity of the plant molecule itself and of the genes that exert
this upregulation. This approach yields distinct, neW

activated receptor (PPAR). These NRPs are knoWn to respond

to speci?c sterol products of plant secondary metabolism, and
have knoWn sequences and pharmacological pro?les. HoW
ever, the systems and methods described herein are adaptable
and applicable to many small molecule plant metabolites With

resources and information. It also makes available a
20

mutageniZed population of plant tissue and Whole plants that

biological activity. Although many of the genes identi?ed by

can be studied further, and it Will provide the genomic data
concerning the overexpres sed genes that lead to the increased

this strategy may have only indirect effects on the pathWays

biological activity. Also, because the plant sequences are

leading to the biologically active products, their characteriza
tion Will help elucidate regulation of secondary metabolism.
Similarly, characterization of the T-DNA and ?anking
sequences Will provide neW information regarding gene
structure and organiZation.
The methods and systems provided by this invention aim to
functionally identify a broad range of genes that in?uence the
production of plant metabolites. The genes identi?ed by these
methods are uncovered in a forward fashion, that is, the effect
of the overexpressed genes on the production of metabolites,

isolated as genomic clones associated With a T-DNA tag,
25

Will also be elucidated. The derived sequences of a particular
plant in Which the studies are conducted Will be informative
for comparative analyses to other plant genomes such as
30

including secondary metabolites, in plant cells is observed.
Upregulated expression of genes as a result of the mutagen
esis step employed in the methods leads to an increased
synthesis of a class of plant metabolites. Consequently, an

35

provided immediately. Speci?cally, overexpression of the
40

molecule activity (in comparison to production of activity
detected in a Wild-type plant). While the total number of plant
genes that in?uences the synthesis of compounds in this Way
may not be large, this approach Will result in the identi?cation
of any gene Which exerts this effect. Thus the primary iden

45

requisite, distinct pathWays involved in the synthesis of a
given plant metabolite is probably common. For example, the

tryptophan pathWay supplies precursors for subsequent, sec
ondary pathWays and a study of its regulation provides
experimental support for this phenomenon. Genes encoding

The types of genes that may be identi?ed using the genet
50

upregulation can be isolated, genes encoding products that

enZymes of the tryptophan pathWay Were found to be upregu
lated in concert to meet the increased demands for synthesis

of the secondary metabolite camalexin, an indolic phytoal
exin, derived from tryptophan (Zhao and Last 1996, Plant

function as pathWay regulators, in signaling, or as pathWay
speci?c enZymes are possible candidates. Many features of
plant secondary metabolism make this one of the most sig

ni?cant aspects of this strategy. The biosynthetic pathWays

address questions relating to hoW pathWays that lead to small
molecule synthesis are signaled. In a handful of pathWays
Well elucidated at the biochemical and genetic levels,
metabolite accumulation in response to an inductive signal
has been shoWn to be the consequence of upregulation of both
the immediate biosynthetic pathWay as Well as the preceding,

“supply” pathWays. This coordinated expression among the

ti?cation of each tagged gene is determined on this functional
basis.

ics-based methods of the invention are conceivably broad.
Because any gene Whose overexpression leads to pathWay

Arabidopsis, rice and maiZe. Finally, the in?uence of each
mutation on the physiology of Whole plants can be observed,
once plant tissue is regenerated from screen-positive calli.
An additional outcome of the high throughput screening
methods and systems provided herein is that an inventory of
sequences that in?uence speci?c small molecule synthesis
Will be made available. Such a collection of genes Will help to

important functional characteristic of the tagged genes is
identi?ed gene leads to increased production of the small

additional genomic sequence information Will be obtained.

Details regarding gene redundancy, density and organiZation

Cell, 812235-2244). This ?nding demonstrated that distinct
primary and secondary pathWays are interlinked and co-regu
55

lated to respond to the requirements for synthesis of a sec

that lead to the production of secondary compounds are
highly diverse and complex, often requiring a large number of

ondary metabolite. A mechanistic explanation for Whole
pathWay coordination is suggested by the recent discovery of

enZymatic steps and multiple regulatory layers. For thor

a transcriptional regulator, ATRl, Which has been shoWn to

oughly studied pathWays, it is noW Well documented that
developmental, temporal and tissue-level control are com
mon regulatory mechanisms for such natural product path
Ways. All of these forms of regulation are evident from
research conducted on a variety of plant speci?c pathWays.

60

5560). This Myb-like transcription factor positively regulates
expression of anthranilate synthase and perhaps additional
genes Within the tryptophan and related secondary pathWays.

One example is the biosynthesis of terpenoids (McGarvey
and Croteau 1995), Which includes a vast assortment of aro

matics and, in many species including Menlha, accumulate in
glandular trichomes at speci?c developmental stages and

control expression for the ?rst step in the tryptophan pathWay
(Bender and Pink 1998, Proc. Natl. Acad. Sci. USA, 95:5655

The increased production of ?avonoids in response to irra
65

diation With ultraviolet light provides another example for
multiple pathWay regulation. Genes Within the primary shiki
mate pathWay and the secondary ?avonoid pathWay Were

US 7,737,327 B2
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found to be selectively coinduced, re?ecting an integrated

The present activity-based screen is conducted at the level

response to enable rapid metabolite accumulation Without

of microcallus tissue, Which is derived from protoplasts
mutageniZed by T-DNA gene activation. The primary steps of

depleting intermediates from the respective pathWays (Lo ge
Thus an emerging vieW is that supply, generally primary,

the screen are generally to nondestructively sample
mutageniZed callus tissue, prepare a crude extract from this

pathWays are appropriately coordinated to maintain homeo

tissue sample and conduct assays for small-molecule activity.

stasis When products or precursors from them are channeled
into the production of neW metabolites (Yao et al. 1995,Plant

The essential property for small molecules of interest is that
they bind to a mammalian receptor of interest, such as the

mann et al. 2000, Proc. Natl. Acad. Sci. USA, 97: 1 903-1907).

glucocorticoid receptor, estrogen receptor, androgen recep

Cell, 711787-1799).

tor, progesterone receptor, mineralocorticoid receptor, liver X
receptor, for example, present in the plant. For these purposes,

Another example of hoW a single gene regulator mediates
changes in small molecule metabolism Was provided by the
isolation of the transcription factor, ORCA3, from Calharan
thus roseus. Overexpression of this regulator results in the
overexpression of a number of metabolite biosynthetic genes

(identifying cultures that overproduce such compounds) it
does not matter Whether the binding activity results in activa
tion (agonists) or inhibition (antagonists) of receptor func
tion. Thus the simplest Way of testing for such compounds is

from more than one pathWay and in turn results in the accu

by a radioligand displacement assay (Gattu et al. 1995, J.

mulation of terpenoid indole alkaloid products. The Orca3

Neurosci. Meth., 631121-125; incorporated herein by refer

regulator also has a role in signaling as it provides for a
mechanism that links small-molecule synthesis to cellular

ence). In this method, a compound that binds With a very high
a?inity and selectivity to the desired NRP is radiolabeled and
alloWed to equilibrate With a membrane fraction containing
the NRP. When unlabelled compounds that also bind to the
NRP are present there is competition for the binding sites
betWeen these and the labeled ligand. As a result, less radio
label Will associate With the membranes.
Other processes that may be used in the present invention
include methodologies to propagate, array and sample the
mutated plant, e.g., callus tissue derived from individual pro
toplasts. Mutated cells are prepared by transformation of

stresses indicated by the level ofjasmonic acid. Finally, and of
relevance to the mutagenic approach to be used here, the

20

ORCA3 gene Was isolated by activation T-DNA tagging in a

positive selection procedure, again demonstrating that path
Way regulators are possible gene candidates With this type of

mutagenesis.

25

The basic method for activation mutagenesis has been
knoWn for several years (FritZe and Walden 1995, Meth. Mol.

Biol., 441281-294; FritZe et al. 1995, Plant 1., 71261-271;
Walden et al. 1995, Meth. Cell Biol., 491455-469, each incor

porated herein by reference). In this technique, enhancer
sequences from the Cauli?ower mosaic virus 35S promoter
are incorporated (via Agrobacteri um mediated T-DNA trans
fer) at random into the plant genome, and produce activation
of genes in the immediate vicinity of the incorporated DNA.
Because the enhancers cause deregulation of promoters

30

35

nearby, gene overexpression generally results, usually con

freshly isolated leaf protoplasts by co-cultivation With Agro
baclerium harboring the activation-tagging T-DNA element.
After this co-cultivation step, protoplasts are Washed and
embedded Within a low-gelling temperature agarose to alloW
development of the transformed protoplast cells, noW under
antibiotic selection for the T-DNA, into microcalli. This gen
erates the primary, mutated tissue in an agarose-embedded
format in 60-mm petri dishes. Typically, 10 to 14 dishes per

ferring a dominant, gain-of-function mutation that is imme

bimonthly experiment are generated, although the total num

diately scorable, making this mutagenesis technique ideally

ber of transforrnants per dish, Which represents an individual

suited for conducting screens at the callus or individual cell
level. Activation of promoters has been found to occur up to

co-cultivation event, in practice is highly variable.
40

integration site (Weigel et al. 2000). In addition, because the
relevant locus is “tagged” With the inserted T-DNA element,
a variety of techniques exist to enable the straightforWard

45

rescue, probably one of the most e?icient genomic cloning

one-half of each sample is used to prepare crude aqueous
50

genetic selection procedures, such as survival of cells or
tissue in the presence of speci?c inhibitors for essential
enZymes (FritZe et al. 1995), in the absence of required

callus groWth media, essentially all of the retained material
can re-groW in the 48-Well dishes, and in this Way a “master”
55

centrifuge tube With a micropestle attached to a loW speed

drill, pelleting the debris by centrifugation at 13,000><g for ten
minutes and transferring the resulting supernatant to fresh
60

tubes. Volumes are precisely set to obtain 700 pL of the

supernatant, for example, to provide 200-p.L samples for dis
placement assays in triplicate.
The basic technology that makes this approach possible is

Thus activation T-DNA tagging has proved effective for the

the use of mammalian nuclear receptor proteins (N RP) in

isolation of a Wide range of different genes in several different

plant species. HoWever, the use of it to create mutations that

mutant tissue library is established. Extracts are prepared, for

example, by macerating the excised tissue portion in a micro

tion of a number of genes involving developmental processes
or other mutations conferring visible phenotypes (BorevitZ et

al. 2000, Plant Cell, 1212383-2394; Huang et al. 2001, Plant
Physiol., 1251573-584; Kardailsky et al. 1999, Science, 2861
1962-5; Weigel et al. 2000, Plant Physiol., 12211003-13).

extracts for displacement assays and the remaining portions
retained in the Wells of the plate. Because the sampling and
extraction steps are conducted under sterile conditions and in

groWth factors (Kakimoto 1996, Science, 2741982-5) or
under restrictive groWth conditions (Furini et al. 1997,
EMBO 1., 1613599-608). Recently, Whole plant screens con
ducted primarily With Arabidopsis have resulted in the isola

microcalli, noW groWn to a diameter of about 0.5 cm, is

conducted by removing a small portion of tissue, for example,
With a pair of ring forceps. The tissue sections may be placed
into Wells of 48-Well microtiter plates Where approximately

recovery of the associated genomic DNA, including plasmid
techniques available. This very poWerful mutagenesis tech
nique has been applied most successfully using positive

At this stage, the microcallus tissue can be “disembedded,”

diluted and surface plated. Once in this form, groWth of the
diluted microcalli, embedded onto the surface of agar-solidi
?ed media, is alloWed to proceed until the material is large
enough to sample. Sampling of the individual, mutated

3.6-kb from the T-DNA insert inArabidopsis and the enhanc
ers function independent of orientation, leading to gene over
expression either upstream or doWnstream from the T-DNA

65

plant cells. These are members of the nuclear steroidhormone

lead to the accumulation of active metabolites that confer no

receptor group, Which include the glucocorticoid (GR), min

visible phenotype previously has not been accomplished.

eralocorticoid, estrogen (ER), androgen, and progesterone

US 7,737,327 B2
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receptors. After becoming activated by binding speci?c hor

seedlings treated With various corticosteroid and steroid
inducers (FIG. 2). This indicated that a variety of inducers

mone molecules in the cytoplasm, the receptor-ligand com
plex moves into the nucleus and activates transcription of
If very feW lines are obtained from the screen that shoW

lead to a level of GFP expression that can be easily detected in
various plant cells. The same construct expressed in tobacco
hoWever, failed to shoW any detectable GFP ?uorescence

constitutive marker expression, e. g., GFP ?uorescence, after
one or tWo rounds of tagging mutagenesis, it is possible to

Whatsoever. After con?rming strong transcriptional induction
using dexamethasone in these transgenic tobacco plants using

alter the sensitivity of the NRP response (Abe et al., 2001,
Biochem. Biophys. Res. Commun., 281:122-125). For
example, it Was shoWn that some polyphenolics, including

RT-PCR, different GFP versions that permit clear ?uores

gallocatechins such as (—)-epigallocatechin-3-O-gallate, can
enhance the activity of a mouse mammary tumor virus pro

ciently screen for the most intense ?uorescing GFP derivative
in tobacco tissue (Yang et al. 2000, Plant J. , 22:543-551).
Separate constructs Were made for each of three different

target genes.

cence detection in tobacco tissue Were evaluated. An Agro
bacZerium-mediated leaf in?ltration method Was used to e?i

moter, Which is also responsive to glucocorticoid induction.

GFP sequences. The original GFP version (Davis andVierstra
1998) used and tWo modi?ed versions Were placed in front of
a constitutive promoter (CaMV 35S) along With a transla

This effect Was only seen When a loW level of inducer (200 nm

dexamethasone) Was present simultaneously (Abe et al.

2001). Thus, sub-induction levels (i.e., transcriptionally
induced but beloW the detection limit for visualiZation of GFP
?uorescence) using dexamethasone or other NRP inducers

tional enhancer (TE) sequence at the 5' end of each GFP

such as (—)-epigallocatechin-3-O-gallate, gallate, catechin,

approach involves the transfer of the 35S::TE::GFP con
structs, Within the T-DNA of a standard plant transformation

and other phenolics can be achieved. For example, the mini
mum concentration of dexamethasone required for visible

coding region (von Amim et al. 1998, Gene, 221:35-43). The
20

vector, into plant cells folloWing manual in?ltration of the
transformed Agrobacleria into the leaf intercellular space

induction of the glucocorticoid receptor is about 0.1 uM.

Nuclear receptors play important roles in human physi

With a syringe plunger. Nicoliana benlhamiana, a tobacco

ological processes by acting as sensors to transduce chemical

signals to changes in gene expression. Their Widespread

25

involvement in diverse areas of metabolism, including many

pathological conditions, make nuclear receptors key thera
peutic targets for the development of neW drugs.
Forty-nine distinct nuclear receptors are encoded in the
human genome. This represents a large set of ligand binding
domains that could be employed as speci?c targets for the

rent Biology, 611653-1663), yielded detectable green ?uores
cence upon excitation With blue light but not With the con
30

coid, estrogen, androgen, and progesterone receptors. A sec
ond nuclear receptor class responds to dietary lipids.
Members of this category include the peroxisome prolifera
tor-activated receptor (PPAR), Which respond to various fatty
acids and is implicated in cellular energy metabolism. Other
potentially useful mammalian receptors for in situ based plant
drug discovery include, the liver X receptor, Which functions
in the regulation of lipid and cholesterol metabolism, the
famesoid X receptor, involved bile acid/cholesterol homeo
stasis, and the vitamin D receptor.
Illustrating the importance of plants as sources of neW
natural products that function as distinct ligands for such
receptors is the recent ?nding that guggelsterone, a com
pound from the Guggul tree, is an antagonist of the farnesoid
X receptor. When supplied to mice reared on a high-choles
terol diet, guggelsterone Was found to decrease hepatic cho
lesterol. This result underscores an important premise of the
in situ detection strategy, Which is that a variety of additional,
unknoWn natural ligands exist for nuclear receptors and that

these may exhibit useful therapeutic potential.

struct harboring the GFP gene used originally. mGFP5
shoWed the most intense ?uorescence on repeated experi
ments. This neW version Was then shoWn to be the only one

detectable under blue ?uorescent light in the tobacco species
used for routine protoplast isolation and mutagenesis, N.

discovery of neW biologically active compounds. Included
among these are nuclear receptors categoriZed as classic
endocrine receptors mediate the action of many steroid hor
mones. This group includes the glucocorticoid, mineralcorti

species on Which this transient expression technique had been
developed and optimiZed, Was ?rst used. TWo GFP
sequences, mGFP4 and mGFP5 (Siemering et al. 1996, Cur

Zabacum SR1.
35

PEG-mediated DNA uptake Was then used as a ?nal tran

sient expression test to determine if GFP ?uorescence could
be visualiZed at the level of single cells isolated from the SR1

line (Walden et al. 1994, Plant Mol. Biol., 26:1521-1528).
40

Fluorescence microscopy of tobacco cells transfected With
the mGFP5 version, along With transfected controls, indi
cated clear GFP ?uorescence that Was Well above back

ground.
Stably transformed SR1 tobacco lines prepared With the
glucocorticoid NRP constructs containing mGFP5 reporter
45

genes Were then generated. Shoots from independently trans
formed lines Were examined for optimal GFP induction char

acteristics using shoot sections treated With 1 and 10 uM
dexamethasone for 12 hours. Ten out of 60 independent lines
50

shoWed very clear GFP ?uorescence and Were transferred to
soil to obtain Whole plants. Leaves from some of these lines
Were used for protoplast isolations to get an early indication

of GFP induction at the single cell stage (FIG. 3). Six out of
the ten of these Were then analyZed at the seedling level and
four lines displayed good induction in all progeny tested at the
55

seedling level (using about 50 seeds) and tWo lines exhibited
the most sensitive induction shoWing clear ?uorescence after
six hours With 1.0 uM dexamethasone.

EXAMPLES

Example 2

Example 1
60

Production of Transgenic NRP-GFP Reporter Lines

Design and Production of an Estrogen-NRP Reporter

Using the basic “GVG” glucocorticoid system developed
by Aoyama, (Aoyama and Chua 1997, Plant J. 11:605-612), a

biosensors to detect biological compounds in the environ

construct using the GFP version, smGFP from Davis and

There is a considerable amount of literature on the use of

Vierstra (Davis andVierstra 1998, Plant Mol. Biol., 36:521-8)

ment. One of the most relevant is the use of genetically
engineered yeast cells as biosensors for the presence of envi

(FIG. 1), Worked Well at the Whole-plant level as detected in

ronmental estrogens (Coldham et al. 1997, Environ.Health

65
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Perspect, 105:734-42) (these come from several sources

through a 105 pm mesh and puri?ed by repeated loW speed
centrifugation (2000 rpm, in a sWing-out rotor), conditions
Whereby intact, viable protoplasts ?oat and nonviable cells

including plants and pesticides). The principle is based on
yeast transfected With a mammalian estrogen receptor (ER)
and ER response element, and this is linked to a gene (the
yeast URA3 gene) to create a positive selection system. In the
presence of estrogen there is overexpression of the URA3
gene and yeast cells survive on synthetic media lacking uracil,
a condition in Which the background yeast strain (a uracil
auxotroph) is unable to survive. The transfected yeast is thus

and debris pellet. Protoplasts are incubated for further steps in
culture dishes at 1><106 cells per 10 mL media.

Transformation With the activator T-DNA tag to

mutageniZe the plant cells is performed by co-cultivation With
Agrobaclerium Zumefaciens, strain GV3101 (KoncZ and
Schell 1986, Mol. Gen. Genet., 204:383-396), harboring the

used as a positive screen for the presence of exogenous estro

gens. Since endogenous estrogens are not produced in yeast
this is not a problem for the screen, but plants produce phy
toestrogens and so the expression of this construct in plant

plasmid pPCVlCEn4HPT (provided by R. Walden), Which
contains the activation T-DNA tagging element (FritZe and
Walden 1995, Meth. Mol. Biol., 44:281-94). Freshly groWn

cells could provide a means of selecting those cells that over

bacterial cells are added directly to six to eight day-old pro
toplast cultures in a ratio of 100:1 bacteria to protoplast cells.
Co-cultivation is conducted at 260 C. in the dark for 48 hours.
At the end of the incubation period, protoplasts are Washed
three times in W5 media (154 mM NaCl, 125 mM

produce phytoestrogens. Because of this, and the fact that
ligands, Which shoW activity at glucocorticoid receptors may
not be as prominent in plant cells, an estrogen-responsive
system also utiliZing a mammalian NRP that Will function in
the same Way as the glucocorticoid-based induction system
has been constructed. This approach provides a means to

20

detect a greater range of plant molecules With ER binding
activity and these include a range of plant polyphenolic mol

centrifugation in a sWing-out rotor at room temperature. Pro
toplasts are resuspended in 0.4 M sucrose K3 media to pro
duce a ?nal concentration of 1><106 protoplasts per mL. One

ecules, including ?avonoids.
The design of the estrogen NRP-based reporter element
folloWs the basic format as that for the GR construct (FIG. 1)

25

(Aoyama and Chua 1997). In this case, the human estrogen
receptor hormone binding domain (hER-HBD) that had been
fused to GAL4 -DNA binding domain and the VP 1 6 transcrip
tional activation domain Was obtained from D. Picard (Univ.

ofGeneva) (Louvion et al. 1993, Gene, 13 1 : 129-34). A PCR
based subcloning strategy Was developed to place this ele

CaCl2~2H2O, 5 mM KCl, 5 mM glucose, pH 5.6-6.0) by

mL of protoplast suspension is transferred to a standard (100
mm) petri dish and cultured in a ?nal volume of 10 mL of 0.4
M sucrose K3 media containing antibiotic selection against
A grobaclerium cells (cefotaxime 500 pg mL_l) as Well as the
presence of hormones to maintain cells in a dedifferentiated

30

state [auxin (naphthalene acetic acid, NAA) 1.0 pg mL‘1 and

cytokinin (kinetin) 0.2 pg mL_l]. Hygromycin (15 pg mL_l)

ment encoding the chimeric estrogen-inducible transcription

or kanamycin (20 pg mL'l), depending on the selectable

factor (GAL4/hER-HBD/VP16) in front of the 35S promoter
of CaMV, and to insert the gene encoding mGFP5 (Siemering
et al. 1996) in front of the 35S minimal promoter-GAL4

markers present on additional versions of the tagging element
We have produced, is also added to the incubation media to
select for the protoplasts transformed With the activation
tagging vector. Control transformations are also performed
With vectors lacking the enhancer sequences, Which provide a

35

upstream activation sequence (see FIG. 1 for conceptual lay
out). Testing and validation of this system Was conducted as

described for the GR-NRP, but using [3-estradiol and other
estrogens, including plant-derived compounds such as ?a
vonoids, Which are knoWn to shoW stimulation of estrogen

means to assess false positives in a given co-cultivation

experiment.
40

responsive element (ERE) promoters (Moosmann and Behl
1999, Proc. Natl. Acad. Sci. USA, 96:8867-72)
The system Was validated by testing for the responsiveness
(i.e., induction of GFP expression by detection of visible GFP
?uorescence) of several classes of plant molecules.

(SeaPlaquee®, FMC Bioproducts, Rockland, Me.). K4
media, a neW media We have adopted for subsequent micro
45

Example 3
Production of a Large Population of Mutant
Protoplasts from the NRP Transgenic N. Tabacum
Lines by A grobaclerium-Mediated ATM

rashige and Skoog 1962, Physiol. Plant, 15:473-497) trans

callus culturing because of more vigorous groWth at this
stage, is then added to the petri dishes containing the soft
agarose-embedded microcalli. This media also contains all
hormones and selective antibiotics as noted above, but

50

This step includes the isolation of protoplasts from the

transgenic lines that express the glucocorticoid receptor-GFP
reporter system i.e., the NRP transgenic lines, and transfor
mation of these cells by Agrobaclerium-mediated T-DNA
transfer, for mutagenesis. Leaf protoplasts are prepared by the
general method as described (Walden et al. 1995, incorpo
rated herein). Brie?y, 4-5 Week old MS media-groWn (Mu

Culturing of protoplasts into microcalli is continued by
embedding the cells in 0.3% loW-gelling temperature agarose

replaces the nitrate salts (NH4NO3 and KNO3) used in the
conventional K3 plant groWth media With glutamine, aspar
agine and arginine (FritZe et al. 1995, Plant 1., 71261-271).
Following protoplast embedding, the K4 media is reduced in
osmolarity at 0.1 M increments, (starting at 0.4 M sucrose,

55

~580 mOsm) on a Weekly basis by changing the liquid phase
media over the soft agarose-embedded cells. Once microcalli
are established (usually four to ?ve Weeks), they are released

60

from the agarose by gentle maceration and dilution. Micro
calli are further cultured by “surface plating” the transformed
tissue to 0.1 M K4 media solidi?ed With agarose in 150 mm

genic tobacco lines harboring the NRP-GFP detection system
are used as a source of leaf material for protoplast isolation.

dishes. Dilutions are made empirically to adjust the number

Leaf pieces from sterile-groWn plants are digested by over
night incubation in a 1.5% cellulase-0.5% pectinase (Sigma)
mixture in plant cell culture medium (K3 media) at 260 C. in
the dark. Released protoplasts are recovered by sieving

of individual microcalli on each dish to densities su?icient to
65

enable clear separation for microscopic screening and for
continued groWth of the microcalli up to the stage of sam

pling.
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Example 4

mutageniZed population is conducted in a single step.

Isolation of those Cells (or Microcalli)

Throughout the recovery process, as the mutated calli are
continuously monitored as noted, positive mutants are con

over-expressing GFP by Micro-Manipulation under
Fluorescence Microscopy

redoubled their mass on the surface of agar-solidi?ed media

?rmed by detecting GFP ?uorescence in microcalli that has

after being divided into small pieces.
Screening for the presence of elevated plant metabolites by

Example 6

?uorescence microscopy can occur soon after embedding

microcalli in agarose. The siZes of the microcalli at this stage
are usually highly variable. Because of this it is advisable to

Use of Extracts of Mutant Microcalli to Con?rm

Increased NRP Biological Activity in a Conventional

adjust the density during embedding as indicated above to
enable the clear visualiZation of smaller microcalli that might
be obscured by larger calli.VisualiZation of GFP ?uorescence
is conducted by placing the petri dishes in Which the micro

Pharmacological Radioligand Binding Screen
GFP-positive tobacco cells derived from the primary
screens are arrayed as microcalli in 48-Well microtiter culture
dishes. Lines groWn in this format can be maintained for

calli is embedded directly on the stage of a Nikon Eclipse TE
200 inverted micro scope, equipped With a super high pres sure
mercury vapor lamp and poWer supply and ?tted With ?lter
blocks for GFP excitation and emission (excitation Wave
lengths: 470-490 nm; emission Wavelengths: 520 nm and

above). Excitation and the resulting ?uorescing illumination
pass directly through the polystyrene lids of the dishes,

periods of four to six months Without the need for further
transfers or additional manipulations. Thus the culture library
provides a master set of mutated material during Which the
20

serves to continually propagate the mutated material as undif
ferentiated tissue as a contingency in the event that regenera

enabling screening to be conducted Without having to open
them and exposing the tissue to non-sterile conditions. Any
?uorescing microcalli are marked on the dish and monitored

for ?uorescence regularly as they develop. Controls alWays

25

The secondary screen consists of pharmacological assays

concentrations (0.1, 1.0 uM) of inducers, generally dexam

conducted on extracts prepared from callus tissue in the mas

ethasone, Will be added. Microcalli that exhibit stable, con
30

ter library. A glucocorticoid receptor binding assay is used to
test extracts of cultures for production of GR ligands. The

methods for radioligand binding to the glucocorticoid recep
tor are modi?ed from described generalized procedures (Kam
et al. 1993, J. Immunol., 151:3460-66; Soldin et al. 1992,

screen and are isolated by manual transfer When the material

has groWn to appropriate sizes. No ?uorescence has been
detected in the absence of exogenously applied chemical
inducers. Thus We expect a loW level of background false
positives for the corticosteriod receptor screen.

tion of any positive callus clones to Whole plants is not pos
sible or e?icient. In such cases, it is possible to isolate
genomic DNA from callus tissue for Southern analysis and

gene cloning procedures.

include transgenic tissue at the same stage to Which various

tinuous ?uorescence under blue-Wavelength light at later
stages of groWth are considered positives for the primary

secondary analysis is conducted. The callus library also

Ther. Drug Monit., 141164-68, both incorporated herein by
35

reference). Radioligand binding is performed to con?rm cor
relation betWeen ligand binding and reporter activity, as Well

Example 5

as to assess the presence of endogenous glucocorticoids in

Establishment of Cells as Mutant Lines

transgenic cultures.
Mammalian steroid receptors are prepared by homogeniZ
40

The activation-tagged plant cells identi?ed from the pri

ing 1 g of ?nely minced rat liver tissue in a solution containing
0.32 mM sucrose, 0.02 mM Tricine, 2mM CaCl2, and 1 mM

mary screen on the surface of agar-solidi?ed media are fur

MgCl2 (pH 7.4), in a hand-held glass homogeniZer and apply

ther groWn to obtain distinct “macrocalli” for sampling and
extract preparation. Continuous monitoring for GFP ?uores

genate is centrifuged at 100,000><g at 40 C. for one hour and

cence is conducted microscopically as the callus tissue devel

ing approximately 30 strokes With a Te?on pestle. The homo
45

the supernatant, containing the cytosolic fraction, is retained.

ops. Sampling is initiated When the surface-plated callus

Protein concentrations are measured using a commercial kit

material attains a siZe of approximately 0.5 to 1.0 cm in

based upon a modi?ed LoWry method (Sigma, St Louis, Mo .).

diameter. Individual calli are sampled by excising approxi

The radiolabeled glucocorticoid ligand is prepared from
stock solutions of [3H]-dexamethasone (Amersham, Arling

mately 50 mg from the callus and performing a “partial”
maceration of this tissue in Wells of a 48-Well microtiterplate.

50

The partial maceration is performed in fresh groWth media,
enabling a small proportion of cells from the callus to remain
intact and viable. The supernatant extract resulting from this
tissue maceration is removed to complete the extraction and
then centrifuged to remove debris. Liquid groWth media is
added to each of the 48 Wells in the plate to replace this and

binding assay is conducted by adding unlabeled and radiola
beled glucocorticoids in ethanol to 10 mL polypropylene
55

tube, and the tubes are incubated for three hours at room

ducted under sterile conditions, the partially disrupted calli
60

library by Which the viable mutageniZed material can be
maintained for several months. Since displacement activity
data from the pharmacological screen is usually obtained
Within one to tWo Weeks of sampling, the material, arrayed in
the 48-Well microtiter plates, can be used to recover any

con?rmed positives. Thus, by this means, sampling, extract
preparation and establishment of a viable library of the

tubes and evaporating under nitrogen gas. 500 ML aliquots of
the glucocorticoid receptor preparation are added to each

these are further incubated to alloW for recovery of the
remaining intact cells. Because all of these steps are con

are able to groW, and this in effect establishes the “master”

ton Heights, Ill.) by addition to 1 mL of 95% ethanol and 9 mL
0.32 mM sucrose. This Working stock solution is then diluted
for a ?nal (per Well) concentration of 10 nM. The radioligand

temperature. Extracts prepared from individual microcalli
displaying stable GFP ?uorescence are used in competition
binding experiments to determine if glucocorticoid small
molecule activity is elevated. All experiments are run in dupli
cate determinations. The binding reaction is terminated by the
addition of 5 mL of ice-cold, 5 mM HEPES buffer containing
0.2 mM EDTA (pH 7.4) and the tube contents are ?ltered

65

through a nitrocellulose ?lter. Data are collected as counts per

minute (CPM) With a Packard Tricarb 2100TR liquid scintil
lation vial counter. Speci?c binding is de?ned as total binding

US 7,737,327 B2
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minus non-speci?c binding, (the latter is determined in the

and comparing pro?les of Wild-type and mutant callus

presence of 10 uM cold dexamethasone). Data are presented

extracts to these. While We can quantify knoWn steroid com

as the mean of pooled replicates :SE. Group means are com

ponents using these methods, the possibility of enhanced GFP

pared by analysis of variance and multiple range testing.
Quanti?cation of the speci?c binding activity is done, for
example, by comparisons to standard curves generated by

mulation of other, perhaps uncharacteriZed, metabolites

?uorescence and displacement activity being due to the accu

makes the examination of these pro?les crucial. For example,
if extracts from mutant tissue displaying reproducible dis
placement activity fail to shoW any quantitative differences in

plotting the CPM of [3H]-dexamethasone standards versus

the concentration of dexamethasone (pg L_l). An activity
table of steroid standards (hydrocortisone, prednisone,

major peaks compared to Wild-type extracts, the chromato
graphic data Will need to be carefully scrutiniZed for the

betamethasone, triamcinolone, and [3-estradiol as a negative
control) Will then be generated, expressing activity as units of

presence of neW peaks, or minor peaks that are of greater
abundance in mutant extracts. These previously absent or
trace-level peaks Will then be examined as thoroughly as

dexamethasone activity equivalents. Concentrations of
unknoWn samples are then estimated based on “dexametha

viously described (expected to be approximately 10%) and

possible by GC-MS analysis. This Will be performed on an
Agilent 6890 GC system coupled to an Agilent 5973 mass

from callus extracts cleared of polyphenolics as Well as glu
cocor‘ticoids. These glucocor‘ticoid-free extracts are prepared

described for GC-FID analysis, With the folloWing modi?ca

sone equivalents”. Non-speci?c binding is determined as pre

selective detector. The conditions used are identical to those

from plant cell culture extracts by centrifugation at 5000><g

tions. The mass spectra are recorded betWeen 40 and 600 amu

for ?ve minutes to remove any cellular debris, and mixing the

With an electron energy of 70 eV. The injector temperature

resulting supernatant (1 mL) With 100 mg activated charcoal.

20

and ion source temperature are set at 300° C. Qualitative

analysis is based upon comparison of retention times and

After incubation at room temperature for tWo hours, the char

coal is removed by Washing 2>< With centrifugation at

spectra With corresponding data logged in the Wiley Library

40,000><g for 20 minutes. This methodology is a variation of

mass spectral database.

a Wide-ranging number of methodologies utiliZed clinically
to estimate blood steroid levels of patients undergoing steroid

25

Example 7

therapy.
Genomic Cloning Techniques (Plasmid Rescue,

Any GFP-positive lines that shoW elevated activity in the
speci?c pharmacological binding assays are folloWed up by
GC/MS analysis of cultures overproducing GR ligands. The

“surface-plating” regime developed during the microcallus

30

screen for alkaloidal activity, are applied to individual callus
clones to amass tissue for extractions. The exclusive use of

The mo st straightforward and ef?cient technique for clon

ing plant genomic DNA ?anking the T-DNA insertion site is

surface-groWn material at these stages (as opposed to bulking
up material by liquid culture groWth) provides a means to
minimize secondary, somatic cell mutations that are possible
if the plant tissue is maintained as rapidly groWing undiffer

plasmid rescue. This approach relies on the bacterial origin of
35

entiated cultures for prolonged periods (Phillips et al. 1994).
Surface-grown callus tissue from individual lines are used

for preparing concentrated extracts for GC analysis. Using
described methods (Bruni et al. 2001), sterols are extracted by
placing 5 g of lyophiliZed callus tissue in 100 mL methanol
and sonicated by treating With continuous, loW poWer ultra
sound for 30 min (SonicatorTM, Heat Systems-Ultrasound,
Inc.). The extraction procedure is performed in darkness
under constant temperature of 25° C. The resulting extract is

Genomic Walking) to Recover Genomic DNA
Adjacent to the Activation T-DNA Tags from the
Individual Lines

40

replication and the ampicillin antibiotic resistance gene
encoded Within the plasmid that is incorporated into the acti
vation-tag T-DNA element (Walden et al. 1995; Weigel et al.
2000; incorporated herein). This method is applied after ?rst
examining the nature of the insert in a given mutant line by
Southern blot analysis. Genomic DNA is isolated from young
plant or callus tissue, Whichever is the most abundant or

available, and Southern analysis is conducted by probing With
45

evaporated to dryness using a rotary evaporator. The resulting
residue is then Weighed, and 50 mg of the sample is cold

fragments of speci?c sequences Within the T-DNA. A kana
mycin resistance gene sequence and a second probe contain
ing sequences Within the bacterial plasmid located Within the
activation T-DNA are typically used. Screen-positive plant or
callus genomic DNA digested With restriction endonucleases

saponi?ed by shaking the sample constantly for 24 hours at

that do not cut Within the T-DNA element (e.g., EcoRI and

room temperature (25° C.) With 5 mL of 1 M methanolic
KOH. The solution is then extracted three times With 2 mL
hexane and 0.2 mL ethanol. The hexane fraction is dried
under nitrogen and the unsaponi?able fraction is silaniZed at
room temperature With a 2-mL mixture containing pyridine/

Notl) is used in a ?rst analysis. Hybridization patterns indi
cating single insertions and siZes greater than that of the

hexamethlydisilaZine/trimethylchlorosilane (5:2:1). After 1
one hour incubation, the liquid is evaporated under nitrogen

50

5.7-kb T-DNA, are candidates for plasmid rescue. We have

had success in performing plasmid rescue using genomic
DNA of the proper siZe range eluted directly from nucleic
acid grade agarose gels as Well as using total genomic DNA
55

Without prior electrophoretic separation. After puri?cation

hexane. The resulting organic fractions are combined and

and concentration of the digested DNA, plasmid rescue is
conducted by ligating the digested genomic DNA en masse to

centrifuged and the resulting supernatant is used directly for

recirculariZe all of the digested fragments and transforming

in an 80° C. Water bath then extracted three times With 0.3 mL

GC analysis. One microliter of this sample is injected into an
Agilent 6890 GC containing a DB-5MS column (30 m><0.25
mm><0.25 pm) with ?ame ioniZation detection using an Agi

60

prevent rearrangements due to the presence of the multimer
iZed enhancers (Weigel et al. 2000). Plasmids isolated from
the resulting ampicillin-resistant colonies are then examined
using standard methods and DNA sequencing. There are also

lent 7360 autosampler system. Chromatographic separation
is obtained by running an oven temperature program that
heats from 2200 C. to 300° C. at 5° C. per min With injector
and detector temperatures set at 300° C. and 350° C., respec

tively. The proportions of the major sterol peaks are estimated
by generating concentration curves using available standards

these by electrporation (BioRad Gene Pulser) into a recom
bination-de?cient E. coli strain (SURE® cells, Stratagene) to

65

restriction enZyme sites that can be employed to rescue

sequences to the right or left half of the T-DNA. That is, there
are sites located on either side of the integrated plasmid
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sequences Within the T-DNA that can be used to recover

controls, including plasmids containing enhancer sequences

genomic DNA only from one side of the T-DNA (Walden et

but no genomic DNA are included. After ?ve days, cells can
be embedded into agarose, as conducted With Agrobacle

al. 1995; Weigel et al. 2000). These various cloning options
usually Will permit the isolation of at least some clones con
taining several kb of genomic DNA. In cases Where these
approaches do not lead to a suf?cient amount of recovered
DNA, even a feW hundred base pairs can be used to probe

genomic libraries to obtain larger, contiguous fragments. In

rium-transformed cells, to enable continued groWth under
selective conditions, but We have found that for examining the
effect of the inserted DNAs in larger, callus tissue, it is more
e?icient to proceed With standard Agrobacerium-mediated

addition, because it is possible to elute speci?c siZe fractions

transformation into Whole tobacco leaves based on the “leaf

from agarose gels and there is an e?icient means to function

dip” transformation protocol. This gives stably transformed

ally test DNA by uptake into transgenic cells, rescued T-DNA

callus faster than Waiting for the single cells from DNA
uptake to groW into microcalli. Moreover, for DNA uptake
into protoplasts, expression is transient, and it may be neces

tags associated With more than one locus can be tested by

independently recovering genomic DNA in separate proce
dures, and then test these individually-derived clones for

sary to evaluate the effect of the transferred sequences in the

activity.

larger, stably expressed callus format. Another factor is the

Example 8
Con?rmation of Gene Function by Re-Incorporation
of Isolated DNA into Protoplasts from the Original

fact that this tissue is also the type on Which the primary
screen is conducted. HoWever, the activity screen is simply by
examination under blue-Wavelength light and thus can also be
20

Transgenic Line

Example 9

The ultimate con?rmation that the recovered tagged gene is

responsible for the small-molecule phenotype is by func
tional analysis of the rescued DNA. Genomic DNA clones
that are associated With the CaMV 35S promoter enhancers
are used. Genomic fragments that are not directly associated
With the enhancers, for example are derived from the left half
of the T-DNA, Which do not contain the enhancer sequences,
or are isolated from genomic libraries, are incorporated into
vectors containing the enhancers to cause the activation of

Determination of All Genomic DNA Sequence
25

30

stages of plasmid rescue, or genomic screening approaches,
35

40

eMachines, San Carlos, Calif.) high pressure shearing device
into suitable, blunt-end digested and phosphatase-treated
50

55

vectors (Oefner et al. 1996). Colonies harboring recombinant
plasmids after transformation With ligated mixtures of clones
Will be automatically gridded to hybridization membranes
and probed With sequences from Within the activation-tag
ging element (e.g., the hygromycin resistance gene, 35S
CaMV enhancer sequences) to identify clones containing
T-DNA. Recombinant clones shoWing the absence of the
main portion of the T-DNA are sequenced.
All output from the ABI automated DNA sequencers is

incubation, 4.4 mL of 0.4 M sucrose-K3 groWth media, con
60

fully readable using LaserGene (DNASTAR, Madison, Wis.)
sequence analysis softWare consisting of SeqMan, EditSeq,
and MegAlign programs, among others. This and the related
packages of DNA analysis programs have been in use in our
laboratories for the past several years and therefore all of the

kinetin) is added. The protoplasts are then transferred to
60-mm petri dishes, sealed With para?lm and incubated at 260
C. in the dark for tWo days. After this time the protoplasts are

placed in the light (20 pE m-2 s_l) in an incubator also at 260

The basic strategy to be folloWed Will be to mechanically

into random fragments centered at 1.8-kb, and cloning these

and incubated 20 minutes at room temperature. After this

taining required groWth factors (NAA 1 pg pL_1, 0.2 pg pL‘l

regions close to the T-DNA borders, Where there can be
incomplete transfer mainly at the 5' end, or the introduction of
extra DNA. For example, sequences derived from the Agro
baclerium binary vector “backbone” can be transferred into
the genome in addition to the T-DNA, and can obscure the

shear each recovered clone using a “HydroShear®” (Gen

are heat shocked at 45° C. for ?ve minutes folloWed by
cooling on ice for tWo minutes. At room temperature, 10 pL of
a DNA sample is added at 1 pg pL_l, and incubated for ten

minutes. At this point a PEG-containing solution consisting
of 0.1 M Ca(NO3)2-4H2O, 0.4 M mannitol, 40% PEG 3350
(Sigma) (pH 7-9), is added and mixed to the cells and DNA

Elucidation of the complete sequence Will only be conducted
on clones examined for proper restriction digest patterns and,

precise insertion point into the genomic DNA.
45

cells by Washing in W5 media in standard polystyrene cen
trifuge tubes, and resuspending in a solution containing 450
mM mannitol, 15 mM MgCl2, 0.1% MES (pH 5.6) to a ?nal
concentration of 1><106 protoplasts per mL. This is used to

prepare 300 pL aliquots of the protoplast suspension, Which

provide a fully sequenced genomic fragment for analysis.
Where necessary, additional analysis by PCR, particularly for

protoplasts from leaves of the same NRP transgenic plants
used for the mutagenesis and screening, Which contain the
hormone receptor based detection system. DNA uptake into

protoplasts is performed by ?rst preparing the isolated plant

The complete nucleotide sequence of all rescued or other
Wise recovered genomic DNA associated With the T-DNA
tags may be obtained. A given genomic clone may not nec
essarily be contiguous, as separate methods may be employed

as described in Objective 5, but these Will all be assembled to

Weigel and others, Which have multiple cloning sites Within a

cloned plant DNA is by transient expression analysis after
polyethylene glycol (PEG) -mediated DNA uptake (Walden et
al. 1995). This method is carried out With freshly prepared

Isolated by High Throughput DNA Sequencing

to recover a suf?ciently siZed portions of DNA, such as tWo

any genes present. Such vectors have been constructed by
T-DNA element containing the 35S enhancers and a plant
selectable marker (Wei gel et al. 2000) and can be used herein.
The fastest means of conducting this functional test With such

monitored continuously and at very early stages.

respective laboratory members have experience With the pro
65

grams. These programs are used extensively to compile,

C. Examination for GFP ?uorescence can occur at this stage

assemble and analyZe sequences, including providing direct

and can be monitored over the next several days. Appropriate

formats to the National databases.
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Example 10

(l) transforming an Arabidopsis or Nicoliana Zabacum
plant With a vector having an estrogen receptor system
comprising a constitutive promoter operably linked to a
nucleotide sequence encoding a trimeric transcription
factor comprising as operatively linked components a

Further Characterization of Genes in Regenerated
Mutant Plants to Establish Whether the Gene

In?uences Product Synthesis at this Level

mammalian estrogen receptor ligand binding domain, a
transcription factor DNA binding domain and a transac

As noted in Example 4, early in the process to con?rm any
?uorescing mutated callus clone, available material is trans
ferred to shoot-inducing media (MS media plus 0.10 mg L-l
NAA 0.5 mg L-l benZylaminopurine). In addition, genetic
material introduced into the NRP-based detector lines during
the evaluation of isolated genomic sequences provides neW

tivating transcriptional activator domain; and a gene
encoding a visible marker operably linked to a transcrip
tion activator sequence and a promoter, to obtain a trans

genic plant;
(2) isolating protoplasts from the transgenic plant of step 1
that express the estrogen receptor system and the gene

stably transformed lines that can be evaluated for GFP ?uo

encoding the visible marker;
(3) mutageniZing the protoplasts of step 2 via T-DNA tag

rescence throughout their development into Whole plants.
This provides tWo important levels of analysis for the

ging mutagenesis to form mutageniZed protoplasts;
(4) culturing the mutageniZed protoplasts of step 3 into
microcalli; and

sequences that are identi?ed. One is the examination of lines

derived independently that overexpress genes associated With
an enhancer, and the other are lines derived from the original,

GFP-positive, microcallus clones.

(5) selecting microcalli of step 4 that overexpress the vis
20

Example 11
Screening Using the Human Estrogen Detector
25

System in Arabidopsis

(b) testing the extract of step (a) for the presence of small
molecules and/or compounds that bind to the estrogen

Putative mutants that accumulate phytoestrogens have

been identi?ed by screening mutageniZed populations of a
transgenic Arabidopsis line harboring a human nuclear recep

receptor ligand binding domain.
3. The method of claim 2 further comprising recovering
30

tor system. The primary genetic screen Was conducted by

examining young seedling roots for expression of the green
?uorescent protein by ?uorescence microscopy. Out of
approximately 8,000 lines screened, a subpopulation of about
49 lines Were scored as putative positive on this basis and used
to generate progeny to perform a secondary screen. A portion

of this population has been examined and some (4-5) indi
viduals exhibited GFP expression as detected by visual
inspection. Whole-seedling extracts Were prepared from this
?rst group and used to determine phytoestrogen “activity”.

ible marker gene in comparison to a control transgenic
microcallus.
2. The method of claim 1 further comprising
(a) preparing an extract of cells removed from a microcal
lus that overexpresses the visible marker gene, Wherein
removal of the cells does not destroy the microcallus;

genomic DNA adjacent to and Within about 5.7 kb of an
activation T-DNA tag in protoplasts or callus tissue that con
tain small molecules or compounds that activate the estrogen

receptor ligand binding domain.
35

4. The method of claim 3 further comprising cloning the
genomic DNA that is recovered into a second vector compris
ing enhancer sequences such that the enhancer sequences are

operably linked to the genomic DNA; transforming proto
40

plasts isolated from plants transformed With the vector of step
(1) With the second vector; and monitoring the protoplasts for
expression of the visible marker gene.
5. The method of claim 1 Wherein the plant is a tobacco

Analysis by estrogen binding displacement assays indicated

plant.

that elevated levels of [3-estradiol-equivalent activities Were
detected in tWo lines compared to a negative control, as indi
cated in Table I.

6. The method of claim 1 Wherein the plant is Arabidopsis.
7. The method of claim 1 Wherein the visible marker gene
45

TABLE I

encodes green ?uorescent protein.
8. The method of claim 2 Wherein the binding of the small
molecule or compound results in activation of the estrogen

Binding Activity in Putative (GFP expression-positive) Lines

receptor.
9. The method of claim 2 Wherein binding to the mamma

Line:
50

Approx. Activity* (nM)

4

5

Neg. control

30

10

0.01

lian estrogen receptor is detected in plant cells or tissues by
the corresponding activation of a visible marker gene.
10. The method of claim 2 Wherein con?rmation of small

molecule activity is by a radioligand displacement assay.

*Activity expressed as [i-estradiol activity equivalents
55

11. The method of claim 1 Wherein the mutageniZed pro
toplasts are exposed to an inducer of the estrogen receptor

ligand binding domain.

Thus, use of a mammalian nuclear receptor in transgenic
plants demonstrates the versality of the invention for screen

12. The method of claim 11 Wherein the inducer is [3-es
tradiol.

ing mutageniZed populations of seedlings or plant cells by the

13. A high throughput screening method for identifying

direct detection of biologically active metabolites.
60

cells that are the source of plant small molecules or com

pounds capable of activating a mammalian estrogen receptor

protein comprising,
What is claimed is:

(1) transforming anArabidopsis or a N Zabacum plant With

1. A high throughput screening method for identifying
plant cells that are the source of compounds that interact With
a mammalian estrogen receptor ligand binding domain com

prising,

a vector comprising a constitutive promoter operably
65

linked to a nucleotide sequence encoding a trimeric tran

scription factor comprising as operatively linked com
ponents a human estrogen receptor hormone binding

US 7,737,327 B2
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domains, a yeast GAL4-DNA binding domain and a

transactivating herpes simplex V16transcriptional acti
Vator domain; and a gene encoding a Visible marker
operably linked to a transcription activator sequence and
a promoter, to obtain a transgenic plant;

(2) isolating protoplasts from the transgenic plant of step 1
that express the gene encoding the Visible marker;

(3) mutageniZing the protoplasts of step 2 Via T-DNA tag

ging mutagenesis to form mutageniZed protoplasts;

20
(4) culturing the mutageniZed protoplasts of step 3 into
microcalli; and
(5) selecting microcalli of step 4 that overexpress the Vis
ible marker gene in comparison to a control transgenic
microcallus.
14. The screening method of claim 13 Wherein the consti
tutive promoter of the Vector is the 35S promoter of the

cauli?ower Mosaic Virus (CaMV).
*

*

*
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